Evidence map›Paper›PMID 42339869›Full record

ArticlemBio2026

Loss of essential outer membrane functions causes drug hypersensitization in

Efrat Hamami, Wenwen Huo, Katherine Neal, Isabelle Neisewander, Shivangi, Joel S Freundlich, Edward Geisinger, Ralph R Isberg

Abstract read
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Efrat HamamiDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0009-0008-1950-3587
Wenwen HuoDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
Katherine NealDepartment of Biochemistry, Curry College, Milton, Massachusetts, USA.
Isabelle NeisewanderDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.
ShivangiDepartment of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, USA.
Joel S FreundlichDepartment of Pharmacology, Physiology, and Neuroscience, Rutgers University-New Jersey Medical School, Newark, New Jersey, USA.
Edward GeisingerDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0001-9661-8072
Ralph R IsbergDepartment of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-8330-3554

Funding

Innovative technologies to transform antibiotic discovery. Project 4 Infection site-specific amplification of antimicrobial conjugatesU19AI142780 · NIAID · BROAD INSTITUTE, INC. · PI BLAINEY, PAUL CLARK · 2019 to 2023
$33.9M
Therapeutics for drug-resistant bacteria: arylmyxopyroninsU19AI189168 · NIAID · HACKENSACK UNIVERSITY MEDICAL CENTER · PI David S Perlin · 2025 to 2026
$22.7M
Predicting the emergence of antibiotic resistance through multi-omics approaches and Immune System-surveillanU01AI124302 · NIAID · BOSTON COLLEGE · PI BENTO, JOSE, COOPER, VAUGHN · 2016 to 2020
$10.2M
Drug resistance enablers and their role in antibiotic treatment failureU19AI158076 · NIAID · BROAD INSTITUTE, INC. · PI COOPER, VAUGHN, ISBERG, RALPH R. · 2022 to 2025
$10.0M
Identification of the Achilles’ heel in Acinetobacter fluoroquinolone-resistant mutantsR21AI128328 · NIAID · TUFTS UNIVERSITY BOSTON · PI ISBERG, RALPH R. · 2017 to 2018
$454k
National Institute of Allergy and Infectious Diseases U01AI124302, U19AI158076, R21AI128328, U19AI142780National Institute of Allergy and Infectious Diseases U19AI189168NIAID NIH HHS R21 AI128328NIAID NIH HHS U01 AI124302NIAID NIH HHS U19 AI142780NIAID NIH HHS U19 AI158076NIAID NIH HHS U19 AI189168
6 · The paper itself

Abstract

Elevated expression of resistance-nodulation-cell division (RND) drug transporters is commonly observed in clinical isolates of IMPORTANCE:

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Outer MembraneBacterial Outer Membrane ProteinsDrug Resistance, Multiple, BacterialMembrane Transport ProteinsBacterial ProteinsCiprofloxacinGenes, EssentialMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsBacterial ProteinsCiprofloxacinMembrane Transport ProteinsAcinetobacter baumanniiantimicrobial combinationsCRISPRimultidrug resistanceRND efflux pumps

Identifiers

PMID42339869
PMCPMC13463702

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.